Source: ecancermedicalscience. Unidade: FM
Subjects: BIOMARCADORES, QUIMIOTERAPIA, NEOPLASIA ENDÓCRINA MÚLTIPLA, NEOPLASIAS PULMONARES
ABNT
RÊGO, Juliana Florinda de M. et al. Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer. ecancermedicalscience, v. 11, 2017Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2017.767. Acesso em: 10 maio 2024.APA
Rêgo, J. F. de M., Medeiros, R. S. S. de, Braghiroli, M. I., Galvão, B., Bezerra Neto, J. E., Munhoz, R. R., et al. (2017). Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer. ecancermedicalscience, 11. doi:10.3332/ecancer.2017.767NLM
Rêgo JF de M, Medeiros RSS de, Braghiroli MI, Galvão B, Bezerra Neto JE, Munhoz RR, Guerra J, Nonogaki S, Kimura L, Pfiffer TE, Castro Jr G de, Hoff PM, Rocha Filho D, Costa FP, Riechelmann RP. Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer [Internet]. ecancermedicalscience. 2017 ; 11[citado 2024 maio 10 ] Available from: https://doi.org/10.3332/ecancer.2017.767Vancouver
Rêgo JF de M, Medeiros RSS de, Braghiroli MI, Galvão B, Bezerra Neto JE, Munhoz RR, Guerra J, Nonogaki S, Kimura L, Pfiffer TE, Castro Jr G de, Hoff PM, Rocha Filho D, Costa FP, Riechelmann RP. Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer [Internet]. ecancermedicalscience. 2017 ; 11[citado 2024 maio 10 ] Available from: https://doi.org/10.3332/ecancer.2017.767